Recombinant esterase from Corynebacterium pseudotuberculosis in DNA and subunit recombinant vaccines partially protects mice against challenge
Author(s) -
Alexandre Antunes Brum,
Andréa de Fátima Silva Rezende,
Francisco Silvestre Brilhante,
Thaís Farias Collares,
Karine Begnine,
Fabiana K. Seixas,
Tiago Collares,
Odir Antônio Dellagostin,
Vasco Azevedo,
Anderson Rodrigues dos Santos,
Ricardo Wagner Portela,
Sibele Borsuk
Publication year - 2017
Publication title -
journal of medical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.91
H-Index - 117
eISSN - 1473-5644
pISSN - 0022-2615
DOI - 10.1099/jmm.0.000477
Subject(s) - recombinant dna , corynebacterium pseudotuberculosis , caseous lymphadenitis , dna vaccination , microbiology and biotechnology , virology , adjuvant , immunization , protein subunit , biology , epitope , antigen , gene , immunology , biochemistry , genetics , bacteria
We tested the efficacy of the esterase encoded by cp1002_RS09720 from Corynebacteriumpseudotuberculosis in recombinant subunit and DNA caseous lymphadenitis (CLA) vaccines. This target was predicted as one of the best CLA vaccine candidates by mature epitope density analysis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom